FDA issues new safety information for statins

The US Food and Drug Administration today issued a new set of warnings and safety recommendations to appear on the labels of cholesterol-lowering statin drugs, which include: Lipitor (atorvastatin), Mevacor (lovastatin), Crestor (rosuvastatin), and Zocor (simvastatin), as well as combination products such as Vytorin (simvastatin/ezetimibe).

Leave a Reply

Your email address will not be published.

*